表紙
市場調査レポート

Laboratorios Del Dr. Esteve S.A.の製品パイプライン分析

Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 259345
出版日 ページ情報 英文 39 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
Laboratorios Del Dr. Esteve S.A.の製品パイプライン分析 Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015
出版日: 2015年04月29日 ページ情報: 英文 39 Pages
概要

当レポートでは、Laboratorios Del Dr. Esteve S.A.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Laboratorios Del Dr. Esteve S.A.の基本情報

Laboratorios Del Dr. Esteve S.A.の概要

  • 主要情報
  • 企業情報

Laboratorios Del Dr. Esteve S.A.:R&Dの概要

  • 主な治療範囲

Laboratorios Del Dr. Esteve S.A.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • 併用療法モダリティ

Laboratorios Del Dr. Esteve S.A.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Laboratorios Del Dr. Esteve S.A.:薬剤プロファイル

  • E-52862
  • HIV用ワクチン

Laboratorios Del Dr. Esteve S.A.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Laboratorios Del Dr. Esteve S.A.:最近のパイプライン動向

Laboratorios Del Dr. Esteve S.A.:休止中のプロジェクト

Laboratorios Del Dr. Esteve S.A.:企業発表

Laboratorios Del Dr. Esteve S.A.:本社と子会社の所在地

Laboratorios Del Dr. Esteve S.A.:主要製造設備

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07029CDB

Summary

Global Markets Direct's, 'Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015', provides an overview of the Laboratorios Del Dr. Esteve S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Del Dr. Esteve S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios Del Dr. Esteve S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios Del Dr. Esteve S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios Del Dr. Esteve S.A.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios Del Dr. Esteve S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios Del Dr. Esteve S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios Del Dr. Esteve S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios Del Dr. Esteve S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Del Dr. Esteve S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios Del Dr. Esteve S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios Del Dr. Esteve S.A. Snapshot
    • Laboratorios Del Dr. Esteve S.A. Overview
    • Key Information
    • Key Facts
  • Laboratorios Del Dr. Esteve S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products Glance
    • Laboratorios Del Dr. Esteve S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Laboratorios Del Dr. Esteve S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Laboratorios Del Dr. Esteve S.A. - Drug Profiles
    • (celecoxib + tramadol hydrochloride)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • E-52862
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lucinactant
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gene Therapy for Sanfilippo A Syndrome
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MuMo-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Analysis
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Target
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Route of Administration
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Molecule Type
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action
  • Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates
  • Laboratorios Del Dr. Esteve S.A. - Dormant Projects
  • Laboratorios Del Dr. Esteve S.A. - Company Statement
  • Laboratorios Del Dr. Esteve S.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Laboratorios Del Dr. Esteve S.A. - Key Manufacturing Facilities
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios Del Dr. Esteve S.A., Key Information
  • Laboratorios Del Dr. Esteve S.A., Key Facts
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Indication, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Del Dr. Esteve S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Combination Treatment Modalities in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products/ Combination Treatment Modalities, 2015
  • Laboratorios Del Dr. Esteve S.A. - Phase II, 2015
  • Laboratorios Del Dr. Esteve S.A. - Phase I, 2015
  • Laboratorios Del Dr. Esteve S.A. - Preclinical, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Target, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Route of Administration, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Molecule Type, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action, 2015
  • Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates, 2015
  • Laboratorios Del Dr. Esteve S.A. - Dormant Developmental Projects,2015
  • Laboratorios Del Dr. Esteve S.A., Subsidiaries
  • Laboratorios Del Dr. Esteve S.A., Key Manufacturing Facilities

List of Figures

  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Indication, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Del Dr. Esteve S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Target, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Route of Administration, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Molecule Type, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top